NCT05625490View on ClinicalTrials.gov

Myocardial Perfusion Imaging Galmydar Rest/Stress

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

November 11, 2022

Primary Completion Date

December 1, 2025

Study Completion Date

December 1, 2025

Conditions
Coronary Artery Disease
Interventions
DRUG

Ga-68 Galmydar

Intravenous injections of the PET radiotracer \[68Ga\]Galmydar.

DRUG

13N-ammonia

Two intravenous injections of PET radiotracer \[13N\]Ammonia.

Trial Locations (1)

63110

RECRUITING

Washington University School of Medicine, St Louis

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Washington University School of Medicine

OTHER